Measles antibody prevalence rates among young adults in Israel

American Journal of Infection Control

Volumn 30, Issue 3, 2002, Pages 165-169

  Gdalevich, Michael ^a   Robin, Guy ^a   Mimouni, Daniel ^b   Grotto, Itamar ^a   Shpilberg, Ofer ^a   Ashkenazi, Isaac ^a  

^a MEDICAL CORPS   (Israel)

^b RABIN MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

MEASLES ANTIBODY; MEASLES VACCINE;

ADULT; ANTIBODY TITER; CONTROLLED STUDY; FEMALE; HEALTH CARE POLICY; HUMAN; IMMUNE RESPONSE; ISRAEL; MAJOR CLINICAL STUDY; MALE; MEASLES; MEASLES VACCINATION; REVIEW; SEROPREVALENCE; SEX RATIO; USSR;

EID: 0036093049     PISSN: 01966553     EISSN: None     Source Type: Journal    
DOI: 10.1067/mic.2002.118617     Document Type: Article

References (26)

1. Failure to reach the goal of measles elimination
2. Review of regional measles surveillance data in the Americas, 1996-99
3. Measles resurgence in Argentina: 1997-8 Outbreak
4. Mortality by cause for eight regions of the world: Global Burden of Disease Study
5. A measles outbreak at a college with a prematriculation immunization requirement
6. Measles control in developing and developed countries: The case for a two-dose policy
7. Measles outbreak-Netherlands, April 1999-January 2000
8. A strategic framework for the elimination of measles in the European region
9. Update-the United States measles epidemic, 1989-1990
10. Immunity to measles in young adults in Israel
11. Measles control in Israel: A decade of the two-dose policy
12. A measles outbreak in the Israel Defense Forces during the 1982 epidemic
13. Prevalence of antibodies against measles, mumps and rubella in Israeli young adults
14. Measles immunity and response to revaccination of a young adult population in Israel
15. Measles
16. Measles-United States, 1999
17. Rapid effect on endemic measles, mumps, and rubella of nationwide vaccination programme in Finland
18. The elimination of indigenous measles, mumps, and rubella from Finland by a 12-year, two-dose vaccination program
19. Measles antibody seroprevalence rates among immunized Inuit. Innu and caucasian subjects
20. Measles antibodies and herd immunity in 20- and 40-year-old Norwegians
21. Herd immunity: History, theory, practice
22. Sex differences in the humoral antibody response to live measles vaccine in young adults
23. Gender differences in the reactogenicity of measles-mumps-rubella vaccine